JW Pharmaceutical Corporation (KRX: 001060)

JW Pharmaceutical Revenue

JW Pharmaceutical had revenue of 172.28B KRW in the quarter ending June 30, 2024, a decrease of -7.34%. This brings the company's revenue in the last twelve months to 742.09B, up 2.74% year-over-year. In the year 2023, JW Pharmaceutical had annual revenue of 748.53B with 9.38% growth.

• Revenue (ttm): 742.09B
• Revenue Growth: +2.74%
• P/S Ratio: 0.76
• Revenue / Employee: 697.45M
• Employees: 1,064
• Market Cap: 600.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	748.53B	64.18B	9.38%
Dec 31, 2022	684.35B	77.77B	12.82%
Dec 31, 2021	606.58B	59.25B	10.83%
Dec 31, 2020	547.34B	36.00B	7.04%
Dec 31, 2019	511.34B	-25.85B	-4.81%